Celularity Inc — Investor Relations & Filings
Celularity Inc. is a clinical and commercial-stage biotechnology company specializing in cellular and regenerative medicine. The company develops and commercializes therapies derived from the postpartum human placenta. Its core focus is on creating off-the-shelf, allogeneic cell therapies, including genetically modified and unmodified Natural Killer (NK) cells, CAR T-cells, and mesenchymal-like adherent stromal cells (MLASCs). These therapeutic programs target a range of conditions, including cancer, immune disorders, and aging-related degenerative diseases. In addition to its clinical pipeline, Celularity markets a suite of commercial placenta-derived biomaterial products. The company leverages the unique biological properties of the placenta to develop accessible treatments for significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-01-21 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 34774203 | 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | ||
| 31588087 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31588249 | 8-K Filing | 2026-01-21 | English | ||
| 13133909 | 4/A | 2026-01-15 | English | ||
| 13133910 | 4/A | 2026-01-15 | English | ||
| 13133912 | 4/A | 2026-01-15 | English | ||
| 13133911 | 4/A | 2026-01-15 | English | ||
| 13133913 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133914 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133915 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133916 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133917 | 424B3 | 2026-01-08 | English | ||
| 13133918 | Regulatory Filings 2026 | 2026-01-08 | English | ||
|
2025
2 filings
| |||||
| 13133919 | S-1 | 2025-12-31 | English | ||
| 13133920 | 4 | 2025-12-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
HARROW, INC.
An eyecare pharmaceutical company that develops and commerc…
|
HROW | US | Manufacturing |
|
HAVN Life Sciences Inc.
Standardized extraction and formulation of psychoactive com…
|
HAVN | CA | Manufacturing |
|
HBM Holdings Limited
Biopharmaceutical company developing novel antibody therape…
|
2142 | KY | Manufacturing |
|
HCW Biologics Inc.
Develops immunotherapies for diseases linked to aging and c…
|
HCWB | US | Manufacturing |
|
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Specializes in the production of heparin-based APIs and ant…
|
300255 | CN | Manufacturing |
|
Hefei Lifeon Pharmaceutical Co., Ltd.
Develops and manufactures cardiovascular, anti-infective, a…
|
003020 | CN | Manufacturing |
|
Heidelberg Pharma AG
Clinical-stage biopharma developing Amanitin-based ADCs for…
|
HPHA | DE | Manufacturing |
|
Heilongjiang ZBD Pharmaceutical Co.,Ltd.
Develops TCM, chemical and biological drugs for cardiovascu…
|
603567 | CN | Manufacturing |
|
Helix BioPharma Corp.
Clinical-stage immune-oncology firm developing bio-conjugat…
|
HBP | CA | Manufacturing |
|
Helixmith Co., Ltd
A biotechnology company specializing in the research and de…
|
084990 | KR | Manufacturing |
Celularity Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34506/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34506 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34506 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34506 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34506}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celularity Inc (id: 34506)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.